193 related articles for article (PubMed ID: 14593570)
1. [Experimental and clinical investigations on the inhibition of secretion of the major salivary glands with botulinum toxin A].
Ellies M
Laryngorhinootologie; 2003 Oct; 82(10):713-4. PubMed ID: 14593570
[No Abstract] [Full Text] [Related]
2. The effect of local injection of botulinum toxin A on the immunoreactivity of nNOS in the rat submandibular gland: an immunohistochemical study.
Ellies M; Schütz S; Quondamatteo F; Laskawi R
Int J Pediatr Otorhinolaryngol; 2006 Jan; 70(1):59-63. PubMed ID: 16002154
[TBL] [Abstract][Full Text] [Related]
3. Temporary reduction of salivation in laryngectomy patients with pharyngocutaneous fistulas by botulinum toxin A injection.
Guntinas-Lichius O; Eckel HE
Laryngoscope; 2002 Jan; 112(1):187-9. PubMed ID: 11802061
[No Abstract] [Full Text] [Related]
4. Successful management of drooling with botulinum toxin A in neurologically disabled children.
Ellies M; Rohrbach-Volland S; Arglebe C; Wilken B; Laskawi R; Hanefeld F
Neuropediatrics; 2002 Dec; 33(6):327-30. PubMed ID: 12571790
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical investigations of the influence of botulinum toxin A on the immunoreactivity of nNOS in the parotid gland of the rat.
Ellies M; Schütz S; Quondamatteo F; Laskawi R
J Oral Maxillofac Surg; 2006 Mar; 64(3):397-401. PubMed ID: 16487800
[TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism.
Mancini F; Zangaglia R; Cristina S; Sommaruga MG; Martignoni E; Nappi G; Pacchetti C
Mov Disord; 2003 Jun; 18(6):685-8. PubMed ID: 12784273
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin to reduce saliva flow: selected indications for ultrasound-guided toxin application into salivary glands.
Ellies M; Laskawi R; Rohrbach-Volland S; Arglebe C; Beuche W
Laryngoscope; 2002 Jan; 112(1):82-6. PubMed ID: 11802043
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound-guided botulinum toxin A injection: an alternative treatment for dribbling.
Marina MB; Sani A; Hamzaini AH; Hamidon BB
J Laryngol Otol; 2008 Jun; 122(6):609-14. PubMed ID: 17640435
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Non Invasive Treatment of Sialorrhea in the Goldenhar Syndrome.
Marvulli R; Gallo GA; Mastromauro L; Dicuonzo F; Fiore P; Ianieri G; Megna M
Endocr Metab Immune Disord Drug Targets; 2018; 18(4):397-400. PubMed ID: 29595115
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical evidence of nNOS and changes after intraglandular application of botulinum toxin A in cephalic salivary glands of adult rats.
Ellies M; Laskawi R; Schütz S; Quondamatteo F
ORL J Otorhinolaryngol Relat Spec; 2003; 65(3):140-3. PubMed ID: 12925814
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin A for drooling in Parkinson's disease: a pilot study to compare submandibular to parotid gland injections.
Kalf JG; Smit AM; Bloem BR; Zwarts MJ; Mulleners WM; Munneke M
Parkinsonism Relat Disord; 2007 Dec; 13(8):532-4. PubMed ID: 17383926
[TBL] [Abstract][Full Text] [Related]
12. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy.
Suskind DL; Tilton A
Laryngoscope; 2002 Jan; 112(1):73-81. PubMed ID: 11802042
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A for control of drooling in Asian patients with cerebral palsy.
Lin YC; Shieh JY; Cheng ML; Yang PY
Neurology; 2008 Jan; 70(4):316-8. PubMed ID: 18209205
[No Abstract] [Full Text] [Related]
14. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
Ellies M; Gottstein U; Rohrbach-Volland S; Arglebe C; Laskawi R
Laryngoscope; 2004 Oct; 114(10):1856-60. PubMed ID: 15454785
[TBL] [Abstract][Full Text] [Related]
15. Treatment of severe drooling with botulinum toxin in amyotrophic lateral sclerosis and Parkinson's disease: efficacy and possible mechanisms.
Møller E; Karlsborg M; Bardow A; Lykkeaa J; Nissen FH; Bakke M
Acta Odontol Scand; 2011 May; 69(3):151-7. PubMed ID: 21198339
[TBL] [Abstract][Full Text] [Related]
16. Parotid and submandibular botulinum toxin A injections for sialorrhoea in children with cerebral palsy.
Banerjee KJ; Glasson C; O'Flaherty SJ
Dev Med Child Neurol; 2006 Nov; 48(11):883-7. PubMed ID: 17044954
[TBL] [Abstract][Full Text] [Related]
17. Salivary gland application of botulinum toxin for the treatment of sialorrhea.
Fuster Torres MA; Berini Aytés L; Gay Escoda C
Med Oral Patol Oral Cir Bucal; 2007 Nov; 12(7):E511-7. PubMed ID: 17978775
[TBL] [Abstract][Full Text] [Related]
18. The effect of local injection of botulinum toxin A on the parotid gland of the rat: an immunohistochemical and morphometric study.
Ellies M; Laskawi R; Tormählen G; Götz W
J Oral Maxillofac Surg; 2000 Nov; 58(11):1251-6. PubMed ID: 11078136
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin for treatment of parkinsonian sialorrhea.
Friedman A; Potulska A
Neurol Neurochir Pol; 2001; 35 Suppl 3():23-7. PubMed ID: 12001650
[TBL] [Abstract][Full Text] [Related]
20. On the relation of calcium channel blockers to rat parotid and submandibular glands function in vivo.
Dehpour AR; Ghafourifar P; Massoudi S; Abdollahi M; Mousavizadeh K
Gen Pharmacol; 1995 May; 26(3):619-22. PubMed ID: 7540580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
